Indian pharma firms may gain market share due to higher US tariffs: Report

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *